We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+74.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.46B
AUM Growth
+$1.09B
Cap. Flow
-$3.1M
Cap. Flow %
-0.07%
Top 10 Hldgs %
49.45%
Holding
523
New
34
Increased
205
Reduced
238
Closed
35

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$149M
2
AMD icon
Advanced Micro Devices
AMD
+$114M
3
ASML icon
ASML
ASML
+$83.3M
4
INTC icon
Intel
INTC
+$69.9M
5
KLAC icon
KLA
KLAC
+$61.9M

Top Sells

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$172M
2
AXTI icon
AXT Inc
AXTI
+$110M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.9M
4
GLW icon
Corning
GLW
+$87.2M
5
TSEM icon
Tower Semiconductor
TSEM
+$79.8M

Sector Composition

Rank Sector Weight
1 Technology 66.9%
2 Consumer Discretionary 12.6%
3 Communication Services 5.91%
4 Miscellaneous 3.42%
5 Healthcare 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MO icon
301
Altria Group
MO
$116B
$446K 0.01%
6,198
-60
-1% -$4.19K
TECH icon
302
Bio-Techne
TECH
$11.4B
$445K 0.01%
6,292
-141
-2% -$7.61K
VERA icon
303
Vera Therapeutics
VERA
$2.52B
$445K 0.01%
10,359
-2,436
-19% -$90.8K
WAT icon
304
Waters Corp
WAT
$40.2B
$444K 0.01%
1,184
-220
-16% -$75K
SMMT icon
305
Summit Therapeutics
SMMT
$13.8B
$444K 0.01%
30,468
-281,357
-90% -$4.99M
COF icon
306
Capital One
COF
$134B
$444K 0.01%
2,211
-116
-5% -$22.2K
CB icon
307
Chubb
CB
$133B
$442K 0.01%
1,296
-58
-4% -$18.9K
IONS icon
308
Ionis Pharmaceuticals
IONS
$9.61B
$442K 0.01%
5,569
-41,119
-88% -$3.09M
A icon
309
Agilent Technologies
A
$42.1B
$440K 0.01%
3,314
-420
-11% -$51.2K
SMCI icon
310
Super Micro Computer
SMCI
$25.4B
$440K 0.01%
14,989
+1,317
+10% +$42K
MTD icon
311
Mettler-Toledo International
MTD
$27B
$437K 0.01%
342
+14
+4% +$16.9K
NBIX icon
312
Neurocrine Biosciences
NBIX
$16B
$433K 0.01%
2,572
-1,917
-43% -$284K
QURE icon
313
uniQure
QURE
$3.1B
$431K 0.01%
9,368
-1,980
-17% -$51.8K
EXEL icon
314
Exelixis
EXEL
$14.5B
$428K 0.01%
7,870
-6,058
-43% -$295K
IQV icon
315
IQVIA
IQV
$43.6B
$424K 0.01%
2,192
-204
-9% -$35.6K
VEEV icon
316
Veeva Systems
VEEV
$44.8B
$422K 0.01%
+2,376
New +$392K
IMVT icon
317
Immunovant
IMVT
$8.08B
$418K 0.01%
10,843
-6,872
-39% -$209K
WST icon
318
West Pharmaceutical
WST
$24.1B
$418K 0.01%
1,163
-393
-25% -$120K
BMRN icon
319
BioMarin Pharmaceuticals
BMRN
$12.7B
$415K 0.01%
7,246
-2,390
-25% -$131K
NUVL
320
DELISTED
Nuvalent
NUVL
$414K 0.01%
3,351
-2,461
-42% -$265K
UTHR icon
321
United Therapeutics
UTHR
$21B
$413K 0.01%
762
-309
-29% -$174K
PWR icon
322
Quanta Services
PWR
$94.1B
$412K 0.01%
572
+29
+5% +$19.8K
HWM icon
323
Howmet Aerospace
HWM
$104B
$404K 0.01%
1,503
-924
-38% -$237K
RMD icon
324
ResMed
RMD
$32.7B
$402K 0.01%
2,064
+197
+11% +$40.8K
LMT icon
325
Lockheed Martin
LMT
$122B
$402K 0.01%
789
+47
+6% +$25.4K
11 12
13
14 15

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, E Fund Management held 523 positions worth $4.46B, up 32% from $3.37B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

E Fund Management's Q2 2026 filing shows 34 new, 205 increased, 238 reduced and 35 closed positions. Its largest new stake was Astera Labs: 196,877 shares worth $95.1M. The largest sale was Lumentum, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 67% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • E Fund Management's largest Q2 2026 buy was Astera Labs: 196,877 shares worth $95.1M.
  • E Fund Management added most to Lam Research in Q2 2026, an estimated $149M increase.
  • E Fund Management's biggest Q2 2026 reduction was Lumentum, cutting an estimated $172M.
  • E Fund Management fully exited SPDR Gold MiniShares Trust in Q2 2026, selling an estimated $13.4M.
  • E Fund Management's ten largest holdings make up 49% of its $4.46B portfolio in Q2 2026.
  • E Fund Management opened 34 new positions and closed 35 in Q2 2026.
  • E Fund Management's portfolio value rose 32% quarter-over-quarter to $4.46B.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.